Less surgery may be enough for rare pancreatic tumor, study suggests
NCT ID NCT07592663
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 708 patients with a rare, low-grade pancreatic tumor called solid pseudopapillary neoplasm. Researchers compared a less invasive surgery that saves healthy pancreas tissue to a more extensive surgery that removes more of the organ. They also examined whether removing nearby lymph nodes is necessary. The goal was to see if the less invasive approach is safe and effective over the long term.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Parenchyma-sparing resection (a less invasive surgery that removes the tumor while saving as much healthy pancreas as possible)
- What this could lead to
- If successful, this could show that less invasive surgery is safe for this rare tumor and that removing lymph nodes may not be necessary, helping patients recover faster with fewer long-term side effects.
- What could go wrong
- This is a completed observational study, not a randomized trial, so results may not apply to all patients. The tumor is low-grade, so the benefits of less surgery may not be as clear for more aggressive cancers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC TUMOR, BENIGN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.